Univest
Univest
  • Markets

MANIPAL HEALTH ENTERPRI L (MANIPALHOS) 52 Week Low Streak: Second Straight Session of Weakness

  • October 22, 2026
  • Posted by: Chaitanya Auti
  • Category: News
No Comments
MANIPAL HEALTH ENTERPRI L 52 Week Low Streak
MANIPAL HEALTH ENTERPRI L (MANIPALHOS) share price is trading within 2% of its 52-week low today and stood at Rs 622.1, down 0.75% from the previous close. Market cap was Rs 82,855.61 crore.

MANIPAL HEALTH ENTERPRI L 52 Week Low Streak has now extended to a second straight session, with the stock trading near its one-year low again and the cumulative move across the streak standing at -1.24%. At 10:22 AM IST, the share price was at Rs 622.1, after touching an intraday low of Rs 616.15. The latest Univest data confirms the repeated-low pattern, but it does not establish a company-specific cause for the continued weakness.

The stock last traded below its previous close of Rs 626.8, after opening at Rs 625.05 and touching a high of Rs 625.05. The market capitalisation stood at Rs 82,855.61 crore. For readers, this repeated pattern matters more than a single-day dip because it shows the stock has remained under pressure across multiple sessions rather than just reacting to one isolated move.

Table of Contents

Toggle
  • MANIPAL HEALTH ENTERPRI L 52 Week Low Streak: Consecutive Low Analysis
  • What the Repeated 52-Week Lows Show
  • MANIPAL HEALTH ENTERPRI L (MANIPALHOS) Fundamental Analysis
  • Sector and Industry Context
  • Peer Comparison
  • Why Investors Are Watching
  • About the Company
  • Frequently Asked Questions
    • Why is MANIPAL HEALTH ENTERPRI L still near its one-year low?
    • How long has the MANIPAL HEALTH ENTERPRI L 52 Week Low Streak lasted?
    • Is the stock setting a new 52-week low today?
    • How does the valuation compare with healthcare peers?
    • What should investors track next in MANIPAL HEALTH ENTERPRI L stock news?
    • Does the current weakness change the company’s market capitalisation story?
  • Track MANIPAL HEALTH ENTERPRI L (MANIPALHOS) Share Price on Univest

MANIPAL HEALTH ENTERPRI L 52 Week Low Streak: Consecutive Low Analysis

Metric Value
Current Price Rs 622.1
Previous Close Rs 626.8
Today's Move Rs -4.7 (-0.75%)
Open Rs 625.05
High Rs 625.05
Low Rs 616.15
Market Capitalisation Rs 82,855.61 crore

MANIPAL HEALTH ENTERPRI L (MANIPALHOS) traded at Rs 622.1 versus the previous close of Rs 626.8, a fall of 0.75%. The stock opened at Rs 625.05, reached a high of Rs 625.05, touched a low of Rs 616.15.

MANIPAL HEALTH ENTERPRI L share price today was at Rs 622.1, down Rs 4.7 or 0.75% from the previous close of Rs 626.8. The stock moved in a narrow band for much of the morning, opening at Rs 625.05 and touching the same level as its intraday high before slipping to Rs 616.15 at the low. That places the current price in the lower part of the day’s range and keeps the stock close to the one-year trough that has been in focus across the last two sessions. The market cap of Rs 82,855.61 crore shows that this is a large listed healthcare name, but size alone does not change the current weakness in the share price.

On a headline basis, the day’s move is modest. On a streak basis, however, the more important point is that MANIPAL HEALTH ENTERPRI L stock news has now remained tied to the same near-low zone for a second straight session. That repeated pattern is what makes the move stand out in a broader stock market update. It also means investors tracking MANIPAL HEALTH ENTERPRI L NSE and MANIPAL HEALTH ENTERPRI L BSE should focus on whether the price can move away from the yearly low band, rather than reading too much into one intraday swing. The current setup still reflects downside pressure, not a reversal.

What the Repeated 52-Week Lows Show

The clearest reading from the MANIPAL HEALTH ENTERPRI L 52 Week Low Streak is that the stock has not only weakened once, but has continued to trade near its 52-week low for a second straight session. The cumulative decline of -1.24% across the streak is a more useful measure than the one-day change because it captures the persistence of the move. In simple terms, this is not just a brief price slip; it is a repeated near-low pattern that has now held across multiple trading sessions.

That matters because the streak can shape how investors interpret the MANIPAL HEALTH ENTERPRI L share price update. A single lower session can be noise. Back-to-back lows suggest the market is still treating the stock cautiously, even if the latest move is relatively small. At the same time, the data confirms the pattern without assigning a reason. For readers following 52 week low stocks, the key takeaway is that repeated weakness often keeps attention on valuation, earnings quality and sector comparison until the share price begins to move away from the one-year low zone.

MANIPAL HEALTH ENTERPRI L (MANIPALHOS) Fundamental Analysis

Metric Value
Market Capitalisation Rs 82,855.61 crore
P/E Ratio 92.4x
P/B Ratio 4.97x
ROE 12.95%
ROCE 13.93%
EPS Rs 6.78
Book Value Per Share Rs 126.18
Dividend Yield 0%

MANIPAL HEALTH ENTERPRI L (MANIPALHOS) fundamental metrics show P/E 92.4x, P/B 4.97x, ROE 12.95%, ROCE 13.93%. These figures provide context only and are not a buy or sell signal.

MANIPAL HEALTH ENTERPRI L has a market capitalisation of Rs 82,855.61 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 92.4x, P/B at 4.97x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 12.95% and ROCE of 13.93%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 6.78, book value per share of Rs 126.18, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.84x, median ROE of 13.07%, median ROCE of 15.83%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric Value
Sector Healthcare
Industry Hospital & Healthcare Services
Benchmark Scope same industry
Company P/E Ratio 92.4x
Benchmark Median P/E 31.84x
Benchmark Average P/E 79.74x
Benchmark P/E Range 0x to 1,528.53x
Company P/B Ratio 4.97x
Benchmark Median P/B 3.57x
Company ROE 12.95%
Benchmark Median ROE 13.07%
Company ROCE 13.93%
Benchmark Median ROCE 15.83%
Company Market Capitalisation Rs 82,855.61 crore
Benchmark Median Market Cap Rs 505.79 crore

MANIPAL HEALTH ENTERPRI L (MANIPALHOS) is classified under sector: Healthcare and industry: Hospital & Healthcare Services.

MANIPAL HEALTH ENTERPRI L (MANIPALHOS) has a P/E ratio of 92.4x, which is above the benchmark median of 31.84x, a difference of +190.2%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

MANIPAL HEALTH ENTERPRI L (MANIPALHOS) has a ROE of 12.95%, which is below the benchmark median of 13.07%, a difference of -0.92%. MANIPAL HEALTH ENTERPRI L (MANIPALHOS) has a ROCE of 13.93%, which is below the benchmark median of 15.83%, a difference of -12%.

Track stocks falling to yearly lows through the Univest 52-week-low screener. The peer table below provides the company-level comparison.

Peer Comparison

Company Symbol Market Cap (Cr) P/E P/B ROE (%) ROCE (%)
Max Healthcare Institute Ltd. MAXHEALTH 80,716.62 54.78 7.3 14.53 14.97
Apollo Hospitals Enterprise Ltd. APOLLOHOSP 1,10,757.32 52.33 11.29 23.54 21.73
Aster DM Healthcare Ltd. ASTERDM 58,157.99 177.79 13.4 13.07 16.22
Fortis Healthcare Ltd. FORTIS 55,553.6 52.45 5.41 11.32 14.07
Narayana Hrudayalaya Ltd. NH 35,602.72 43.21 7.43 19.86 16.2

MANIPAL HEALTH ENTERPRI L (MANIPALHOS) has a P/E ratio of 92.4x compared with the displayed peer median of 52.45x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 12.95% compares with a peer median of 14.53% across the companies shown in the table. ROCE stood at 13.93% versus the displayed peer median of 16.2%, providing a capital-efficiency comparison. MANIPAL HEALTH ENTERPRI L (MANIPALHOS) has a market capitalisation of Rs 82,855.61 crore. Among the 5 peers shown, only 1 has a larger market capitalisation.

Why Investors Are Watching

  • The stock is in a second straight session of trading near its 52-week low, which keeps the MANIPAL HEALTH ENTERPRI L 52 Week Low Streak in focus.
  • The cumulative move across the streak is -1.24%, showing repeated weakness rather than a one-off dip.
  • The share price remains below the previous close, keeping the short-term stock performance under pressure.
  • Valuation remains rich versus the healthcare industry median on both P/E and P/B.
  • Investors will likely watch whether the price can move away from the yearly low band and whether fundamentals support the premium multiple.

About the Company

MANIPAL HEALTH ENTERPRI L operates in the hospital and healthcare services space and is part of the broader Healthcare sector. The company is one of the larger listed names in the industry by market capitalisation, which places it in regular focus for stock market update coverage and healthcare stock news. Its financial profile includes a P/E ratio of 92.4, P/B ratio of 4.97, ROE of 12.95%, ROCE of 13.93%, EPS of Rs 6.78 and book value of Rs 126.18.

For investors tracking MANIPAL HEALTH ENTERPRI L share price movements, the current interest is less about a single session and more about the repeated trade near the yearly low. That is why this MANIPAL HEALTH ENTERPRI L 52 Week Low Streak matters as a separate research angle. It combines price action, valuation and sector context into one simple question: can the stock stop trading close to its one-year trough?

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Registration Number INH000013776), a subsidiary of Univest Communication Technologies Private Limited.

Frequently Asked Questions

Why is MANIPAL HEALTH ENTERPRI L still near its one-year low?

Ans. The latest Univest data confirms that the stock has traded near its 52-week low for a second straight session, but it does not identify a company-specific trigger. The pattern points to persistent weakness, not to a named cause.

How long has the MANIPAL HEALTH ENTERPRI L 52 Week Low Streak lasted?

Ans. The stock has now traded within 2% of its 52-week low for two consecutive sessions. That is why the current read is described as a second straight session of near-low trading.

Is the stock setting a new 52-week low today?

Ans. No such claim should be made from the current data. The stock is trading near its 52-week low, but the event definition here is proximity to the trough, not necessarily a fresh low.

How does the valuation compare with healthcare peers?

Ans. The company’s P/E of 92.4 is above the industry median of 31.84 and also above several listed peers. Its P/B of 4.97 is likewise above the industry median of 3.57.

What should investors track next in MANIPAL HEALTH ENTERPRI L stock news?

Ans. Investors should watch whether the share price remains stuck near the yearly low band or starts moving away from it. They should also monitor whether fundamentals can justify the premium valuation relative to the healthcare sector.

Does the current weakness change the company’s market capitalisation story?

Ans. No, market capitalisation still shows the company as a large healthcare name at Rs 82,855.61 crore. However, size does not prevent the stock from trading near a one-year low when price pressure persists.

Track MANIPAL HEALTH ENTERPRI L (MANIPALHOS) Share Price on Univest

Use MANIPAL HEALTH ENTERPRI L (MANIPALHOS) live share-price page, Univest 52-week-low screener, Univest market blogs to review live stock data, yearly-low lists and related market analysis.



Leave a Reply Cancel reply